BioLife Solutions, Inc. (BLFS)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance

Current Price

as of Jan 10, 2025

$26.61

P/E Ratio

N/A

Market Cap

$1.23B

Description

BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs, generic blood stem cell freezing and cell thawing media products and custom product formulation and custom packaging services. The company was founded by Boris Rubinsky in 1987 and is headquartered in Bothell, WA.

Metrics

Overview

  • HQBothell, WA
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerBLFS
  • Price$26.61-3.90%

Trading Information

  • Market cap$1.23B
  • Float96.76%
  • Average Daily Volume (1m)303,463
  • Average Daily Volume (3m)387,105
  • EPS-$0.82

Company

  • Revenue$123.36M
  • Rev growth (1yr)-8.27%
  • Net income-$1.70M
  • Gross margin50.33%
  • EBITDA margin2.48%
  • EBITDA$0.76M
  • EV$1.16B
  • EV/Revenue9.41
  • P/EN/A
  • P/S9.96
  • P/B3.78
Documents